title: Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay.
abstract: Cellular prion protein, a membrane protein, is expressed in all mammals. Prion protein is also found in human blood as an anchorless protein, and this protein form is one of the many potential sources of misfolded prion protein replication during transmission. Many studies have suggested that β-amyloid1-42 oligomer causes neurotoxicity associated with Alzheimer's disease, which is mediated by the prion protein that acts as a receptor and regulates the hippocampal potentiation. The prevention of the binding of these proteins has been proposed as a possible preventative treatment for Alzheimer's disease; therefore, a greater understanding of the binding hot-spots between the two molecules is necessary. In this study, the epitope mapping immunoassay was employed to characterize binding epitopes within the prion protein and complementary epitopes in β-amyloid. Residues 23-39 and 93-119 in the prion protein were involved in binding to β-amyloid1-40 and 1-42, and monomers of this protein interacted with prion protein residues 93-113 and 123-166. Furthermore, β-amyloid antibodies against the C-terminus detected bound β-amyloid1-42 at residues 23-40, 104-122 and 159-175. β-Amyloid epitopes necessary for the interaction with prion protein were not determined. In conclusion, charged clusters and hydrophobic regions of the prion protein were involved in binding to β-amyloid1-40 and 1-42. The 3D structure appears to be necessary for β-amyloid to interact with prion protein. In the future, these binding sites may be utilized for 3D structure modeling, as well as for the pharmaceutical intervention of Alzheimer's disease.
authors.affiliation: Department of Bionanotechnology, Gachon University, Gyeonggi, Korea.
authors.forename: Mino
authors.initials: M
authors.lastname: Kang
authors.forename: Su Yeon
authors.initials: SY
authors.lastname: Kim
authors.forename: Seong Soo A
authors.initials: SS
authors.lastname: An
authors.forename: Young Ran
authors.initials: YR
authors.lastname: Ju
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism*; D004586:Electrophoresis; D004797:Enzyme-Linked Immunosorbent Assay; D018604:Epitope Mapping; D000939:Epitopes / Q000378:metabolism*; D006801:Humans; D007118:Immunoassay; D000072002:Prion Proteins; D011328:Prions / Q000378:metabolism*; D011485:Protein Binding; D011994:Recombinant Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D000939:Epitopes; C512656:PRNP protein, human; D000072002:Prion Proteins; D011328:Prions; D011994:Recombinant Proteins
references.citation: Exp Neurol. 1997 Jul;146(1):104-12
references.pmid: 9225743
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16742-7
references.pmid: 12481027
references.citation: J Biol Chem. 2001 Oct 19;276(42):39145-9
references.pmid: 11522774
references.citation: J Pharmacol Exp Ther. 2007 Jun;321(3):823-9
references.pmid: 17229880
references.citation: Nature. 1992 Apr 16;356(6370):577-82
references.pmid: 1373228
references.citation: J Cereb Blood Flow Metab. 2012 Apr;32(4):628-32
references.pmid: 22293988
references.citation: Am J Pathol. 2000 Jan;156(1):15-20
references.pmid: 10623648
references.citation: Nat Med. 2004 Jul;10 Suppl:S10-7
references.pmid: 15272267
references.citation: J Biol Chem. 2005 Mar 25;280(12):11247-58
references.pmid: 15618225
references.citation: PLoS One. 2011;6(9):e25675
references.pmid: 21980526
references.citation: Histopathology. 2001 Feb;38(2):120-34
references.pmid: 11207825
references.citation: Neuron. 2002 Feb 28;33(5):677-88
references.pmid: 11879646
references.citation: EMBO Mol Med. 2010 Aug;2(8):289-90
references.pmid: 20698011
references.citation: Can J Neurol Sci. 2012 May;39(3):286-98
references.pmid: 22547507
references.citation: J Alzheimers Dis. 2012;30(3):675-84
references.pmid: 22451321
references.citation: IUBMB Life. 2007 Apr-May;59(4-5):332-45
references.pmid: 17505973
references.citation: Mol Neurodegener. 2008 Aug 21;3:11
references.pmid: 18718018
references.citation: Nat Struct Mol Biol. 2010 May;17(5):561-7
references.pmid: 20383142
references.citation: Science. 2002 Jul 19;297(5580):353-6
references.pmid: 12130773
references.citation: Science. 1992 Apr 10;256(5054):184-5
references.pmid: 1566067
references.citation: Neuron. 2004 Sep 30;44(1):181-93
references.pmid: 15450169
references.citation: FEBS Lett. 1997 Nov 17;417(3):400-4
references.pmid: 9409760
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
references.pmid: 9811807
references.citation: Mol Neurobiol. 1994 Apr-Jun;8(2-3):121-7
references.pmid: 7999308
references.citation: Transl Neurodegener. 2012 Sep 21;1(1):18
references.pmid: 23210692
references.citation: Annu Rev Neurosci. 2003;26:267-98
references.pmid: 12704221
references.citation: Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
references.pmid: 17245412
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1971-6
references.pmid: 19188609
references.citation: Brain Res Mol Brain Res. 2004 Apr 29;124(1):40-50
references.pmid: 15093684
references.citation: J Immunol Methods. 2002 Sep 1;267(1):13-26
references.pmid: 12135797
references.citation: J Vet Med Sci. 2004 May;66(5):515-20
references.pmid: 15187361
references.citation: Acta Neuropathol. 2010 May;119(5):523-41
references.pmid: 20354705
references.citation: FASEB J. 2005 Feb;19(2):255-7
references.pmid: 15548589
references.citation: J Biol Chem. 2002 Oct 25;277(43):40810-5
references.pmid: 12181315
references.citation: Prion. 2013 Jan-Feb;7(1):37-41
references.pmid: 22987042
references.citation: Physiol Rev. 2010 Apr;90(2):465-94
references.pmid: 20393191
references.citation: Mol Neurobiol. 2002 Oct-Dec;26(2-3):299-316
references.pmid: 12428762
references.citation: J Leukoc Biol. 2007 Jun;81(6):1374-85
references.pmid: 17379700
references.citation: BMC Struct Biol. 2005 Sep 30;5:18
references.pmid: 16197548
references.citation: Ann Neurol. 1994 Apr;35(4):385-95
references.pmid: 8154865
references.citation: J Neurosci. 2007 Mar 14;27(11):2866-75
references.pmid: 17360908
references.citation: Handb Clin Neurol. 2008;89:245-60
references.pmid: 18631749
references.citation: J Biol Chem. 2010 Aug 20;285(34):26377-83
references.pmid: 20576610
references.citation: Nature. 2010 Aug 12;466(7308):E3-4; discussion E4-5
references.pmid: 20703260
references.citation: Trends Neurosci. 2001 Apr;24(4):219-24
references.pmid: 11250006
references.citation: Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72
references.pmid: 15465622
references.citation: J Biol Chem. 2008 Apr 4;283(14):9359-68
references.pmid: 18234671
references.citation: Curr Protoc Immunol. 2004 May;Chapter 9:Unit 9.4
references.pmid: 18432936
references.citation: J Immunol Methods. 1987 Sep 24;102(2):259-74
references.pmid: 2443575
references.citation: Methods. 1996 Jun;9(3):473-81
references.pmid: 8812703
references.citation: Nature. 2009 Feb 26;457(7233):1128-32
references.pmid: 19242475
references.citation: EMBO Mol Med. 2010 Aug;2(8):306-14
references.pmid: 20665634
references.citation: Cell Death Differ. 2005 Jul;12(7):783-95
references.pmid: 15846375
references.citation: J Neurosci Res. 2002 Jan 15;67(2):211-24
references.pmid: 11782965
references.citation: Neuron. 2010 Jun 10;66(5):631-45
references.pmid: 20547123
references.citation: PLoS One. 2012;7(11):e49375
references.pmid: 23145167